125 related articles for article (PubMed ID: 36604246)
1. Factors associated with pathological tumor stage and T3a upstage in clinical T1-2 renal cell carcinoma.
Kalfazade N; Özlü DN; Şam E; Akkaş F; Gürbüz N
Prog Urol; 2023 Mar; 33(3):135-144. PubMed ID: 36604246
[TBL] [Abstract][Full Text] [Related]
2. The Preoperative Predictive Factors for Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma.
Fukui S; Miyake M; Iida K; Onishi K; Hori S; Morizawa Y; Kagebayashi Y; Fujimoto K
Diagnostics (Basel); 2019 Jul; 9(3):. PubMed ID: 31311108
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of renal tumor contour irregularity score in pathological T3a upstaging of clinical T1 renal cell carcinoma: A multi-institutional study.
Xu P; Zhang S; Cao B; Li Y; Huang J; Lin W; Cheng J; Li H; Chen W; Zhu Y; Jiang S; Hu X; Wu J; Wu Z; Zhou J; Guo J; Wang H
Urol Oncol; 2022 May; 40(5):199.e1-199.e8. PubMed ID: 35365414
[TBL] [Abstract][Full Text] [Related]
4. The preoperative predictive factors for pathological T3a upstaging and positive surgical margin of clinical T1 renal cell carcinoma.
Çil G; Yilmaz M; Sahin Y; Ulus I; Canıtez IO; Kandıralı IE
Actas Urol Esp (Engl Ed); 2024 May; 48(4):311-318. PubMed ID: 38369290
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria.
Hamilton ZA; Capitanio U; Pruthi D; Ghali F; Larcher A; Patel DN; Eldefrawy A; Patel S; Cotta BH; Bradshaw AW; Meagher MF; Miller NS; Carenzi C; Wan F; Liss MA; McGregor T; Montorsi F; Derweesh IH
Urology; 2020 Apr; 138():60-68. PubMed ID: 31836465
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors and oncological outcomes of pathological T3a upstaging in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.
Ishiyama R; Omae K; Kondo T; Iizuka J; Yoshida K; Fukuda H; Tachibana H; Ishihara H; Kobayashi H; Takagi T
Jpn J Clin Oncol; 2024 Feb; 54(2):160-166. PubMed ID: 37840320
[TBL] [Abstract][Full Text] [Related]
7. The De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Prognosticator in Patients With End-stage Renal Disease-associated Renal Cell Carcinoma.
Ikeda T; Ishihara H; Takagi T; Fukuda H; Yoshida K; Iizuka J; Kobayashi H; Okumi M; Ishida H; Kondo T; Tanabe K
Clin Genitourin Cancer; 2020 Jun; 18(3):236-240.e1. PubMed ID: 31917171
[TBL] [Abstract][Full Text] [Related]
8. Outcomes and predictors of clinical T1 renal mass (cT1) upstaged to pathological T3a (pT3a) after partial nephrectomy: A single-center experience.
Pathak N; Ganpule A; Patel D; Singh A; Shete N; Sabnis R; Desai M
Int J Urol; 2024 Mar; 31(3):252-257. PubMed ID: 38124339
[TBL] [Abstract][Full Text] [Related]
9. Pathological Upstaging of Clinical T1 to Pathological T3a Renal Cell Carcinoma: A Multi-institutional Analysis of Short-term Outcomes.
Nayak JG; Patel P; Saarela O; Liu Z; Kapoor A; Finelli A; Tanguay S; Rendon R; Moore R; Black PC; Lacombe L; Breau RH; Kawakami J; Drachenberg DE
Urology; 2016 Aug; 94():154-60. PubMed ID: 27041471
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Pre-to-Postoperative Dynamics of Aspartate Transaminase/Alanine Transaminase Ratio in Predicting the Prognosis of Renal Cell Carcinoma after Surgical Treatment.
Kang M; Shin SJ; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Seo SI
Dis Markers; 2020; 2020():8887605. PubMed ID: 32724485
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: emphasis on partial nephrectomy.
Lee H; Lee M; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
BMC Cancer; 2018 Apr; 18(1):427. PubMed ID: 29661179
[TBL] [Abstract][Full Text] [Related]
12. A novel nomogram can predict pathological T3a upstaged from clinical T1a in localized renal cell carcinoma.
Cao C; Kang X; Shang B; Shou J; Shi H; Jiang W; Xie R; Zhang J; Zhang L; Zheng S; Bi X; Li C; Ma J
Int Braz J Urol; 2022; 48(5):784-794. PubMed ID: 35838503
[TBL] [Abstract][Full Text] [Related]
13. Oncological outcomes and pathological characteristics of cT1 upstaging to pT3a renal cell carcinoma compared with de novo pT3a tumors.
Senguttuvan Karthikeyan V; Mallya A; Sivaraman A; Galiano M; Rozet F; Cathala N; Barret E; Mombet A; Prapotnich D; Sanchez-Salas R; Cathelineau X
Actas Urol Esp (Engl Ed); 2019 Jun; 43(5):234-240. PubMed ID: 30857765
[TBL] [Abstract][Full Text] [Related]
14. Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging.
Jeong SH; Kim JK; Park J; Jeon HJ; Yoon MY; Jeong CW; Ku JH; Kim HH; Kwak C
PLoS One; 2016; 11(11):e0166183. PubMed ID: 27861519
[TBL] [Abstract][Full Text] [Related]
15. Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a.
Shah PH; Moreira DM; Patel VR; Gaunay G; George AK; Alom M; Kozel Z; Yaskiv O; Hall SJ; Schwartz MJ; Vira MA; Richstone L; Kavoussi LR
J Urol; 2017 Aug; 198(2):289-296. PubMed ID: 28274620
[TBL] [Abstract][Full Text] [Related]
16. Partial nephrectomy in two patients with known T3a tumours involving the renal vein.
Kim EH; Jain S; Benway BM; Figenshau RS
BJU Int; 2012 May; 109(9):1345-8. PubMed ID: 21883846
[TBL] [Abstract][Full Text] [Related]
17. Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis.
Patel SH; Uzzo RG; Larcher A; Peyronnet B; Lane BR; Pruthi D; Reddy M; Capitanio U; Joshi S; Noyes S; Eldefrawy A; Ghali F; Meagher MF; Hamilton ZA; Yim K; Nasseri R; Bradshaw AW; Dey S; Kirmiz S; Wan F; Liss MA; Bensalah K; Montorsi F; Derweesh IH
Clin Genitourin Cancer; 2020 Dec; 18(6):e723-e729. PubMed ID: 32600941
[TBL] [Abstract][Full Text] [Related]
18. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
Liu S; Feng C; Liu C; Wang Z
Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
[TBL] [Abstract][Full Text] [Related]
19. Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors.
Mouracade P; Kara O; Dagenais J; Maurice MJ; Nelson RJ; Malkoc E; Kaouk JH
World J Urol; 2017 Sep; 35(9):1425-1433. PubMed ID: 28197727
[TBL] [Abstract][Full Text] [Related]
20. Elevated neutrophil to lymphocyte and platelet to lymphocyte ratios predict high grade and advanced stage renal cell carcinoma.
Çalışkan S
Int J Biol Markers; 2019 Mar; 34(1):15-19. PubMed ID: 30852956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]